Evidence map›Paper›PMID 15345523›Full record

ArticleBiophysical journal2004

A signal transduction pathway model prototype I: From agonist to cellular endpoint.

Thomas J Lukas

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Use of virtual cell in studies of cellular dynamics.International review of cell and molecular biology · 2010
    Review
  7. Article
  8. CellML metadata standards, associated tools and repositories.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2009
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas J LukasDepartment of Molecular Pharmacology and Drug Discovery Program, Northwestern University, Chicago, Illinois 60611, USA. t-lukas@northwestern.edu
Northwestern University · US

Funding

VIRTUAL FCSP41RR013186 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LOEW, LESLIE M · 1998 to 2011
$14.2M
NCRR NIH HHS 5P41RR013186NCRR NIH HHS P41 RR013186
6 · The paper itself

Abstract

The postgenomic era is providing a wealth of information about the genes involved in many cellular processes. However, the ability to apply this information to understanding cellular signal transduction is limited by the lack of tools that quantitatively describe cellular signaling processes. The objective of the current studies is to provide a framework for modeling cellular signaling processes beginning at a plasma membrane receptor and ending with a measurable endpoint in the signaling process. Agonist-induced Ca(2+) mobilization coupled to down stream phosphorylation events was modeled using knowledge of in vitro and in vivo process parameters. The simulation process includes several modules that describe cellular processes involving receptor activation phosphoinositide metabolism, Ca(2+)-release, and activation of a calmodulin-dependent protein kinase. A Virtual Cell-based simulation was formulated using available literature data and compared to new and existing experimental results. The model provides a new approach to facilitate hypothesis-driven investigation and experimental design based upon simulation results. These investigations may be directed at the timing of multiple phosphorylation/dephosphorylation events affecting key enzymatic activities in the signaling pathway.

Indexed as

Signal TransductionAnimalsCalciumCell MembraneCytoplasmEndoplasmic ReticulumEnzyme ActivationHumansKineticsLigandsModels, BiologicalModels, ChemicalModels, TheoreticalMuscle ContractionMyosin-Light-Chain KinaseMyosinsCalciumLigandsMyosin-Light-Chain KinaseMyosinsPhosphatidylinositolsReceptors, BradykininType C Phospholipases

Identifiers

PMID15345523
PMCPMC1304549
OpenAlexW2071658020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.